ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Yi Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0548-2742; OpenAlex author ID A5026303573. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

O-GlcNAcylation of FBP1 promotes pancreatic cancer progression by facilitating its Lys48-linked polyubiquitination in hypoxic environments. Co-author DOI 10.1038/s41389-025-00555-4 ↗
O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. Co-author DOI 10.1038/s41418-022-00984-3 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaoman He · 2 shared papers, 2022–2025 · strength 0.49
- Paper O-GlcNAcylation of FBP1 promotes pancreatic cancer progression by facilitating its Lys48-linked polyubiquitination in h… DOI 10.1038/s41389-025-00555-4 ↗
- Paper O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. DOI 10.1038/s41418-022-00984-3 ↗
Wei Feng · 1 shared paper, 2025 · strength 0.33
- Paper O-GlcNAcylation of FBP1 promotes pancreatic cancer progression by facilitating its Lys48-linked polyubiquitination in h… DOI 10.1038/s41389-025-00555-4 ↗
Jiali Gong · 1 shared paper, 2022 · strength 0.16
- Paper O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. DOI 10.1038/s41418-022-00984-3 ↗
Lei Zheng · 1 shared paper, 2022 · strength 0.16
- Paper O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. DOI 10.1038/s41418-022-00984-3 ↗
Yulian Wu · 1 shared paper, 2022 · strength 0.16
- Paper O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. DOI 10.1038/s41418-022-00984-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.